Antimycobacterial [EPC]

Antimycobacterial [EPC] was reported 24388 times

Drugs of the Antimycobacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 109 0.5989
1 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 193 0.5761
2 SERPIGINOUS CHOROIDITIS 24 0.5000
3 TYPE 2 LEPRA REACTION 90 0.4813
4 TYPE 1 LEPRA REACTION 17 0.3333
5 VAGINAL FLATULENCE 90 0.2970
6 TUBERCULOSIS OF EYE 18 0.2571
7 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 65 0.2399
8 TUBERCULOID LEPROSY 15 0.2308
9 INTERFERON GAMMA RELEASE ASSAY POSITIVE 34 0.2073
10 MENINGITIS TUBERCULOUS 111 0.1986
11 DIAPHRAGMATIC INJURY 13 0.1757
12 LEPROMATOUS LEPROSY 14 0.1647
13 PARADOXICAL DRUG REACTION 602 0.1635
14 SIDEROBLASTIC ANAEMIA 22 0.1571
15 DEMODICIDOSIS 13 0.1413
16 PERICARDITIS TUBERCULOUS 14 0.1400
17 MYCOBACTERIUM FORTUITUM INFECTION 25 0.1351
18 NICOTINIC ACID DEFICIENCY 15 0.1351
19 MYCOBACTERIUM ABSCESSUS INFECTION 95 0.1329
20 ACID FAST BACILLI INFECTION 20 0.1242
21 TOXIC OPTIC NEUROPATHY 50 0.1152
22 TUBERCULOSIS GASTROINTESTINAL 36 0.1129
23 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 22 0.0995
24 IMMUNE RECONSTITUTION SYNDROME 128 0.0991
25 EXTRAPULMONARY TUBERCULOSIS 29 0.0983
26 PERITONEAL TUBERCULOSIS 43 0.0979
27 DISSEMINATED TUBERCULOSIS 250 0.0974
28 LYMPH NODE TUBERCULOSIS 69 0.0927
29 BONE TUBERCULOSIS 35 0.0914
30 PULMONARY TUBERCULOSIS 378 0.0884
31 CHOROIDITIS 33 0.0882
32 TUBERCULOUS PLEURISY 41 0.0867
33 INTESTINAL TUBERCULOSIS 15 0.0862
34 CUTANEOUS TUBERCULOSIS 15 0.0824
35 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 37 0.0792
36 MYCOBACTERIUM HAEMOPHILUM INFECTION 21 0.0734
37 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 340 0.0682
38 MYCOBACTERIUM TEST POSITIVE 14 0.0680
39 HEPATIC HAEMATOMA 31 0.0654
40 CONGESTIVE HEPATOPATHY 26 0.0580
41 OPTIC NEUROPATHY 121 0.0571
42 MYCOBACTERIAL INFECTION 98 0.0568
43 HEPATITIS TOXIC 146 0.0560
44 HEPATITIS B CORE ANTIBODY POSITIVE 21 0.0557
45 BOVINE TUBERCULOSIS 21 0.0548
46 FEMALE GENITAL TRACT FISTULA 93 0.0544
47 OTOTOXICITY 100 0.0540
48 PANCREATITIS HAEMORRHAGIC 25 0.0539
49 MYCOBACTERIUM AVIUM COMPLEX INFECTION 138 0.0514
50 PSOAS ABSCESS 29 0.0465
51 INFECTIVE ANEURYSM 23 0.0465
52 LATENT TUBERCULOSIS 84 0.0401
53 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 48 0.0400
54 GRANULOMATOUS LIVER DISEASE 28 0.0398
55 URINARY TRACT INFLAMMATION 14 0.0389
56 CEREBELLAR ATAXIA 36 0.0376
57 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 939 0.0365
58 RADICULOPATHY 93 0.0353
59 JARISCH-HERXHEIMER REACTION 25 0.0351
60 HEPATOTOXICITY 779 0.0350
61 BRONCHOPLEURAL FISTULA 13 0.0346
62 THALAMIC INFARCTION 20 0.0337
63 DRUG-INDUCED LIVER INJURY 1041 0.0331
64 ATYPICAL MYCOBACTERIAL INFECTION 45 0.0318
65 PROCTITIS 89 0.0317
66 SPUTUM CULTURE POSITIVE 25 0.0308
67 TUBERCULIN TEST POSITIVE 77 0.0304
68 RENAL TRANSPLANT FAILURE 30 0.0304
69 OEDEMATOUS PANCREATITIS 17 0.0303
70 MULTIPLE-DRUG RESISTANCE 94 0.0303
71 ANTIPSYCHOTIC DRUG LEVEL DECREASED 16 0.0301
72 LOSS OF EMPLOYMENT 91 0.0301
73 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 66 0.0278
74 DRUG RESISTANCE 695 0.0270
75 MARROW HYPERPLASIA 18 0.0264
76 CHRONIC SINUSITIS 99 0.0264
77 COMA HEPATIC 19 0.0256
78 CENTRAL NERVOUS SYSTEM VASCULITIS 13 0.0255
79 GRANULOMA 88 0.0254
80 HEPATITIS FULMINANT 74 0.0249
81 DEAFNESS NEUROSENSORY 82 0.0249
82 GLOMERULONEPHRITIS MINIMAL LESION 18 0.0248
83 CEREBRAL TOXOPLASMOSIS 23 0.0246
84 OCULAR TOXICITY 27 0.0245
85 ELECTROCARDIOGRAM QT PROLONGED 871 0.0242
86 ACUTE HEPATIC FAILURE 326 0.0238
87 STRONGYLOIDIASIS 37 0.0229
88 MYCOBACTERIUM CHELONAE INFECTION 16 0.0217
89 DELAYED GRAFT FUNCTION 15 0.0211
90 PULMONARY CAVITATION 18 0.0207
91 HILAR LYMPHADENOPATHY 18 0.0205
92 HYPERURICAEMIA 83 0.0202
93 PULMONARY GRANULOMA 23 0.0201
94 BILIRUBIN CONJUGATED INCREASED 47 0.0201
95 LYMPHOCYTE STIMULATION TEST POSITIVE 16 0.0200
96 MICROCYTIC ANAEMIA 41 0.0197
97 COLOUR BLINDNESS 18 0.0196
98 OPTIC ATROPHY 31 0.0190
99 LIVER TRANSPLANT REJECTION 34 0.0189
100 COMPLICATIONS OF TRANSPLANTED KIDNEY 42 0.0185
101 FOCAL DYSCOGNITIVE SEIZURES 21 0.0184
102 HEPATITIS 472 0.0184
103 CHRONIC RESPIRATORY FAILURE 22 0.0182
104 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 20 0.0182
105 PNEUMOCYSTIS JIROVECI PNEUMONIA 40 0.0179
106 HYDROCEPHALUS 97 0.0178
107 LYMPHADENITIS 43 0.0177
108 INFECTIOUS PLEURAL EFFUSION 27 0.0177
109 ANAEMIA OF CHRONIC DISEASE 16 0.0177
110 HEPATIC ENCEPHALOPATHY 164 0.0176
111 HEPATIC NECROSIS 66 0.0175
112 LICHENOID KERATOSIS 40 0.0175
113 VESTIBULAR DISORDER 21 0.0171
114 OPTIC NEURITIS 155 0.0170
115 HEPATOSPLENOMEGALY 43 0.0167
116 HYPERTRANSAMINASAEMIA 116 0.0167
117 JAUNDICE 436 0.0162
118 ERYTHRODERMIC PSORIASIS 13 0.0158
119 ADRENOCORTICAL INSUFFICIENCY ACUTE 30 0.0154
120 CRYPTOCOCCOSIS 25 0.0153
121 PNEUMONIA CRYPTOCOCCAL 14 0.0148
122 PATHOGEN RESISTANCE 135 0.0148
123 ACINETOBACTER INFECTION 16 0.0146
124 CARDIOPULMONARY FAILURE 57 0.0146
125 HIV INFECTION 44 0.0146
126 ORAL CANDIDIASIS 192 0.0146
127 CHOLESTATIC LIVER INJURY 32 0.0144
128 LIVER TRANSPLANT 50 0.0137
129 COR PULMONALE 13 0.0136
130 DRUG LEVEL DECREASED 133 0.0131
131 CEREBRAL VENTRICLE DILATATION 15 0.0130
132 HEPATITIS CHOLESTATIC 78 0.0129
133 CACHEXIA 66 0.0128
134 TRANSAMINASES INCREASED 284 0.0128
135 ALCOHOL POISONING 34 0.0127
136 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 28 0.0125
137 RENAL ATROPHY 15 0.0120
138 DERMATITIS EXFOLIATIVE GENERALISED 40 0.0115
139 LYMPHADENOPATHY MEDIASTINAL 22 0.0115
140 MENINGITIS CRYPTOCOCCAL 20 0.0114
141 HENOCH-SCHONLEIN PURPURA 25 0.0114
142 EOSINOPHILIA 197 0.0112
143 TRISOMY 21 14 0.0111
144 POLYNEUROPATHY 133 0.0111
145 BLOOD BICARBONATE DECREASED 21 0.0111
146 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 36 0.0111
147 STENOTROPHOMONAS INFECTION 15 0.0111
148 DISTRIBUTIVE SHOCK 25 0.0110
149 NEURITIS 17 0.0110
150 ENCEPHALITIS 75 0.0108
151 RASH MORBILLIFORM 30 0.0108
152 CYTOMEGALOVIRUS CHORIORETINITIS 21 0.0108
153 PSEUDOMEMBRANOUS COLITIS 24 0.0107
154 BICYTOPENIA 21 0.0107
155 BRONCHIECTASIS 72 0.0107
156 EMPYEMA 21 0.0106
157 NOCARDIOSIS 27 0.0105
158 RESPIRATORY ALKALOSIS 17 0.0104
159 SPLENIC INFARCTION 18 0.0103
160 HEPATIC CYST 35 0.0103
161 HEPATIC STEATOSIS 190 0.0102
162 ASPERGILLUS INFECTION 66 0.0100
163 SKIN HYPERPIGMENTATION 86 0.0100
164 TRANSPLANT REJECTION 80 0.0100
165 BLOOD HIV RNA INCREASED 18 0.0099
166 TYPE IV HYPERSENSITIVITY REACTION 27 0.0098
167 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 15 0.0098
168 VAGINAL DISCHARGE 97 0.0096
169 HYPERBILIRUBINAEMIA 99 0.0095
170 HEPATITIS ACUTE 62 0.0095
171 OESOPHAGEAL CANDIDIASIS 38 0.0095
172 TRANSPLANT DYSFUNCTION 17 0.0095
173 DEAFNESS BILATERAL 16 0.0094
174 ASPARTATE AMINOTRANSFERASE INCREASED 500 0.0094
175 CD4 LYMPHOCYTES DECREASED 20 0.0093
176 BLOOD CREATININE DECREASED 29 0.0093
177 PNEUMONIA KLEBSIELLA 17 0.0092
178 SPUTUM INCREASED 20 0.0092
179 OCULAR ICTERUS 40 0.0092
180 HEPATOMEGALY 89 0.0090
181 APLASIA PURE RED CELL 31 0.0090
182 DERMATITIS EXFOLIATIVE 45 0.0090
183 HYPERLACTACIDAEMIA 24 0.0089
184 BLOOD CHLORIDE DECREASED 23 0.0089
185 FUNGAEMIA 14 0.0089
186 IRIDOCYCLITIS 28 0.0089
187 ALANINE AMINOTRANSFERASE INCREASED 544 0.0089
188 HEPATIC FAILURE 267 0.0088
189 OSTEOLYSIS 18 0.0088
190 HYPERSENSITIVITY VASCULITIS 23 0.0088
191 MIXED LIVER INJURY 26 0.0086
192 HEPATIC CYTOLYSIS 110 0.0086
193 VASCULAR PSEUDOANEURYSM 15 0.0086
194 LUNG CONSOLIDATION 24 0.0086
195 HEPATOCELLULAR DAMAGE 19 0.0084
196 COMPUTERISED TOMOGRAM ABNORMAL 19 0.0084
197 LIVER INJURY 205 0.0083
198 LUNG OPACITY 22 0.0083
199 ELECTROCARDIOGRAM T WAVE ABNORMAL 13 0.0083
200 BRAIN ABSCESS 21 0.0083
201 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 62 0.0083
202 ENCEPHALOPATHY 201 0.0082
203 NECROSIS 45 0.0081
204 ESCHERICHIA URINARY TRACT INFECTION 34 0.0080
205 BLOOD ALBUMIN DECREASED 63 0.0079
206 INTRACRANIAL PRESSURE INCREASED 43 0.0077
207 LYMPHADENOPATHY 271 0.0076
208 PANCREATITIS CHRONIC 18 0.0076
209 RASH MACULO-PAPULAR 168 0.0075
210 BLOOD CHLORIDE INCREASED 13 0.0075
211 LONG QT SYNDROME 18 0.0075
212 BILE DUCT OBSTRUCTION 14 0.0074
213 DISSEMINATED INTRAVASCULAR COAGULATION 103 0.0073
214 HAEMOPTYSIS 204 0.0073
215 DRUG INTERACTION 1154 0.0073
216 LIVER FUNCTION TEST ABNORMAL 211 0.0072
217 HAEMOLYTIC ANAEMIA 65 0.0072
218 NEUROPATHY PERIPHERAL 690 0.0072
219 PLEURISY 43 0.0072
220 PSEUDOMONAS INFECTION 62 0.0072
221 PNEUMONIA BACTERIAL 66 0.0072
222 TYPE I HYPERSENSITIVITY 25 0.0071
223 HEPATOCELLULAR INJURY 100 0.0070
224 MENINGITIS 47 0.0070
225 AUTOIMMUNE HAEMOLYTIC ANAEMIA 24 0.0070
226 NEPHROPATHY TOXIC 78 0.0069
227 HEPATIC FUNCTION ABNORMAL 257 0.0069
228 BLOOD BILIRUBIN INCREASED 186 0.0069
229 CHEST X-RAY ABNORMAL 21 0.0068
230 PNEUMOTHORAX 108 0.0068
231 CONCOMITANT DISEASE AGGRAVATED 42 0.0068
232 HISTIOCYTOSIS HAEMATOPHAGIC 20 0.0067
233 PARAESTHESIA ORAL 97 0.0067
234 DRUG ERUPTION 119 0.0067
235 PROTHROMBIN TIME PROLONGED 40 0.0067
236 BLOOD PRESSURE DIASTOLIC ABNORMAL 17 0.0067
237 TOXIC EPIDERMAL NECROLYSIS 101 0.0066
238 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 22 0.0066
239 MUCORMYCOSIS 17 0.0065
240 LYMPHOCYTOSIS 14 0.0065
241 MACULE 18 0.0065
242 ANTINUCLEAR ANTIBODY POSITIVE 21 0.0065
243 LUNG INFILTRATION 57 0.0064
244 MACULAR DEGENERATION 77 0.0064
245 MALNUTRITION 72 0.0064
246 GENERALISED TONIC-CLONIC SEIZURE 106 0.0064
247 IMMUNE SYSTEM DISORDER 83 0.0063
248 HYPOVOLAEMIC SHOCK 30 0.0063
249 FOETAL GROWTH RESTRICTION 38 0.0062
250 COAGULOPATHY 104 0.0062
251 SPLENOMEGALY 73 0.0062
252 PAPILLOEDEMA 28 0.0062
253 MYOCARDITIS 71 0.0062
254 LOW BIRTH WEIGHT BABY 49 0.0062
255 ACUTE PSYCHOSIS 15 0.0061
256 HEPATIC ENZYME INCREASED 411 0.0060
257 LIVER DISORDER 266 0.0060
258 DRUG LEVEL BELOW THERAPEUTIC 33 0.0060
259 NEPHROTIC SYNDROME 41 0.0060
260 ELECTROLYTE IMBALANCE 69 0.0059
261 BRONCHOPULMONARY ASPERGILLOSIS 46 0.0059
262 ELECTROCARDIOGRAM T WAVE INVERSION 13 0.0059
263 ADENOVIRUS INFECTION 17 0.0059
264 PURULENT DISCHARGE 25 0.0058
265 BLOOD ALKALINE PHOSPHATASE INCREASED 145 0.0058
266 RENAL CYST 46 0.0058
267 GAMMA-GLUTAMYLTRANSFERASE INCREASED 128 0.0058
268 PANCREATITIS ACUTE 129 0.0057
269 LYMPHOPENIA 81 0.0057
270 AMYLASE INCREASED 21 0.0057
271 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 14 0.0057
272 PULMONARY MASS 84 0.0056
273 ABDOMINAL TENDERNESS 28 0.0056
274 STILLBIRTH 27 0.0056
275 FACE OEDEMA 94 0.0056
276 CARDIAC FAILURE ACUTE 37 0.0055
277 GASTROENTERITIS 81 0.0055
278 BLOOD URIC ACID INCREASED 32 0.0055
279 KLEBSIELLA INFECTION 28 0.0055
280 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 43 0.0055
281 OLIGURIA 34 0.0055
282 HALLUCINATIONS, MIXED 23 0.0055
283 TUBULOINTERSTITIAL NEPHRITIS 102 0.0054
284 TOOTH DISCOLOURATION 16 0.0054
285 PLEURITIC PAIN 15 0.0054
286 NEUROTOXICITY 95 0.0054
287 CHOLESTASIS 104 0.0054
288 RENAL TUBULAR NECROSIS 53 0.0054
289 HYPOALBUMINAEMIA 42 0.0054
290 OLIGOHYDRAMNIOS 18 0.0054
291 CREPITATIONS 16 0.0054
292 PANCYTOPENIA 299 0.0053
293 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 27 0.0053
294 MULTIPLE ORGAN DYSFUNCTION SYNDROME 151 0.0053
295 SUPRAVENTRICULAR EXTRASYSTOLES 18 0.0053
296 RESPIRATORY FAILURE 387 0.0053
297 PERIPHERAL SENSORY NEUROPATHY 31 0.0053
298 ANAEMIA 1006 0.0053
299 AREFLEXIA 14 0.0052
300 LIVER ABSCESS 17 0.0052
301 ALCOHOL ABUSE 14 0.0052
302 PERICARDIAL EFFUSION 121 0.0052
303 DEAFNESS 136 0.0052
304 COMA SCALE ABNORMAL 15 0.0052
305 CYTOMEGALOVIRUS VIRAEMIA 23 0.0052
306 HYPERREFLEXIA 18 0.0052
307 TOXIC SKIN ERUPTION 52 0.0052
308 HEPATITIS B 31 0.0051
309 DYSLIPIDAEMIA 26 0.0051
310 PAPULE 36 0.0051
311 BRAIN OEDEMA 64 0.0051
312 WOUND DEHISCENCE 17 0.0050
313 LEUKOCYTOSIS 91 0.0050
314 PSYCHOTIC DISORDER 148 0.0050
315 SUBCUTANEOUS ABSCESS 24 0.0050
316 VASCULITIS 58 0.0050
317 ACIDOSIS 38 0.0050
318 ACUTE RESPIRATORY FAILURE 95 0.0049
319 TOXIC ENCEPHALOPATHY 25 0.0049
320 SUSPECTED OFF LABEL USE 22 0.0049
321 LUPUS-LIKE SYNDROME 44 0.0048
322 CYTOLYTIC HEPATITIS 16 0.0048
323 FAILURE TO THRIVE 25 0.0048
324 CLOSTRIDIUM DIFFICILE COLITIS 51 0.0048
325 IMMUNE THROMBOCYTOPENIA 22 0.0048
326 DRUG LEVEL ABOVE THERAPEUTIC 22 0.0048
327 KIDNEY TRANSPLANT REJECTION 23 0.0048
328 METABOLIC ACIDOSIS 153 0.0048
329 HYPERTRIGLYCERIDAEMIA 28 0.0048
330 CREATININE RENAL CLEARANCE DECREASED 19 0.0047
331 PIGMENTATION DISORDER 29 0.0047
332 ACUTE RESPIRATORY DISTRESS SYNDROME 83 0.0047
333 STUPOR 15 0.0047
334 NORMOCHROMIC NORMOCYTIC ANAEMIA 14 0.0047
335 HYPERCAPNIA 14 0.0046
336 SEROTONIN SYNDROME 89 0.0046
337 ARTHRITIS BACTERIAL 19 0.0046
338 LIVER FUNCTION TEST INCREASED 99 0.0046
339 BLOOD UREA INCREASED 77 0.0046
340 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 25 0.0046
341 HYPOKALAEMIA 212 0.0046
342 ASCITES 135 0.0046
343 STEVENS-JOHNSON SYNDROME 101 0.0045
344 THROMBOTIC THROMBOCYTOPENIC PURPURA 16 0.0045
345 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 40 0.0045
346 INCORRECT PRODUCT ADMINISTRATION DURATION 98 0.0045
347 PNEUMOCYSTIS JIROVECII PNEUMONIA 45 0.0045
348 VIROLOGIC FAILURE 24 0.0045
349 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17 0.0044
350 SKIN NECROSIS 23 0.0044
351 IMMUNOSUPPRESSION 39 0.0044
352 PLEURAL EFFUSION 268 0.0044
353 BRAIN HERNIATION 13 0.0043
354 ATELECTASIS 42 0.0043
355 NYSTAGMUS 23 0.0043
356 BACTERIAL SEPSIS 14 0.0043
357 BACTERAEMIA 51 0.0043
358 DYSAESTHESIA 13 0.0042
359 C-REACTIVE PROTEIN INCREASED 154 0.0042
360 LUNG NEOPLASM 18 0.0042
361 CYTOMEGALOVIRUS INFECTION 70 0.0042
362 EOSINOPHIL COUNT INCREASED 35 0.0042
363 BLOOD SODIUM DECREASED 79 0.0042
364 PURPURA 37 0.0042
365 LIPASE INCREASED 32 0.0042
366 SHOCK 96 0.0042
367 SERUM FERRITIN INCREASED 22 0.0042
368 SKIN LESION 114 0.0042
369 ENTEROCOCCAL INFECTION 20 0.0041
370 RALES 24 0.0041
371 TREATMENT NONCOMPLIANCE 226 0.0041
372 DRUG LEVEL INCREASED 68 0.0041
373 FACIAL PARALYSIS 35 0.0041
374 PYREXIA 1411 0.0041
375 PSYCHIATRIC SYMPTOM 30 0.0041
376 LACTIC ACIDOSIS 131 0.0040
377 VENTRICULAR EXTRASYSTOLES 42 0.0040
378 EXPOSURE DURING PREGNANCY 250 0.0040
379 HYPOMAGNESAEMIA 56 0.0040
380 EXPOSURE VIA BREAST MILK 16 0.0040
381 DEAFNESS UNILATERAL 22 0.0040
382 THROMBOCYTOPENIA 446 0.0040
383 GENERALISED OEDEMA 49 0.0040
384 SEPTIC SHOCK 171 0.0039
385 MYELOSUPPRESSION 141 0.0039
386 POLYURIA 32 0.0039
387 CONTRAINDICATED PRODUCT ADMINISTERED 118 0.0039
388 STATUS EPILEPTICUS 44 0.0039
389 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 40 0.0039
390 CHOLECYSTITIS ACUTE 22 0.0039
391 ATAXIA 46 0.0039
392 HERPES SIMPLEX 25 0.0038
393 LEUKOPENIA 192 0.0038
394 CUTANEOUS VASCULITIS 14 0.0038
395 TACHYPNOEA 52 0.0038
396 HAEMODIALYSIS 32 0.0038
397 PROCEDURAL PAIN 104 0.0037
398 SKIN MASS 25 0.0037
399 PROTEIN TOTAL DECREASED 14 0.0037
400 MULTI-ORGAN FAILURE 64 0.0037
401 MATERNAL EXPOSURE DURING BREAST FEEDING 15 0.0037
402 ALTERED STATE OF CONSCIOUSNESS 80 0.0037
403 GRAND MAL CONVULSION 34 0.0037
404 HAEMODYNAMIC INSTABILITY 28 0.0037
405 FREQUENT BOWEL MOVEMENTS 99 0.0037
406 DRUG INTOLERANCE 352 0.0036
407 ORGANISING PNEUMONIA 18 0.0036
408 INFLAMMATORY MARKER INCREASED 18 0.0036
409 RED BLOOD CELL SEDIMENTATION RATE INCREASED 40 0.0036
410 BLOOD CREATINE INCREASED 16 0.0036
411 GASTROINTESTINAL PERFORATION 15 0.0036
412 PULSELESS ELECTRICAL ACTIVITY 15 0.0036
413 SPUTUM DISCOLOURED 34 0.0036
414 PRODUCTIVE COUGH 171 0.0036
415 BLOOD CALCIUM DECREASED 40 0.0036
416 PNEUMONIA FUNGAL 14 0.0035
417 ERYTHEMA MULTIFORME 33 0.0035
418 PULMONARY TOXICITY 25 0.0035
419 PLATELET COUNT INCREASED 46 0.0035
420 TREATMENT FAILURE 292 0.0035
421 AZOTAEMIA 14 0.0035
422 BLOOD MAGNESIUM DECREASED 30 0.0035
423 EMPHYSEMA 35 0.0035
424 UVEITIS 47 0.0035
425 ENTEROCOLITIS 20 0.0035
426 VISUAL FIELD DEFECT 25 0.0035
427 AUTOIMMUNE HEPATITIS 24 0.0034
428 GASTROINTESTINAL DISORDER 309 0.0034
429 RESPIRATORY DISTRESS 95 0.0034
430 INTERNATIONAL NORMALISED RATIO INCREASED 98 0.0034
431 CYSTIC FIBROSIS 19 0.0034
432 HEMIPARESIS 58 0.0034
433 HEPATIC ENZYME ABNORMAL 17 0.0034
434 NEUTROPHILIA 19 0.0033
435 PULMONARY FIBROSIS 64 0.0033
436 BONE MARROW FAILURE 67 0.0033
437 TINNITUS 150 0.0033
438 COLITIS ULCERATIVE 145 0.0032
439 SKIN DISCOLOURATION 149 0.0032
440 PYELONEPHRITIS 28 0.0032
441 BLOOD LACTIC ACID INCREASED 17 0.0032
442 TENDON DISORDER 21 0.0032
443 PROTEINURIA 61 0.0032
444 PULMONARY HAEMORRHAGE 25 0.0032
445 CHROMATURIA 72 0.0032
446 PREMATURE LABOUR 18 0.0032
447 DEMYELINATION 13 0.0032
448 PETECHIAE 33 0.0032
449 SARCOIDOSIS 15 0.0032
450 BLOOD CREATININE INCREASED 206 0.0032
451 GASTRITIS 83 0.0032
452 RESPIRATORY RATE INCREASED 28 0.0032
453 HEMIPLEGIA 26 0.0031
454 TORSADE DE POINTES 24 0.0031
455 INTERSTITIAL LUNG DISEASE 148 0.0031
456 BREATH SOUNDS ABNORMAL 15 0.0030
457 ANOREXIA 39 0.0030
458 RASH PUSTULAR 22 0.0030
459 DERMATITIS ALLERGIC 38 0.0030
460 PREMATURE DELIVERY 48 0.0030
461 COLITIS 114 0.0030
462 CHOLECYSTITIS CHRONIC 20 0.0030
463 SINUS TACHYCARDIA 42 0.0030
464 CARDIAC FAILURE 237 0.0029
465 MOUTH ULCERATION 62 0.0029
466 AMMONIA INCREASED 15 0.0029
467 HYPERCALCAEMIA 36 0.0029
468 CENTRAL NERVOUS SYSTEM LESION 40 0.0029
469 REFUSAL OF TREATMENT BY PATIENT 19 0.0029
470 ANURIA 25 0.0029
471 BLOOD LACTATE DEHYDROGENASE INCREASED 46 0.0029
472 CANDIDA INFECTION 49 0.0029
473 RASH VESICULAR 14 0.0029
474 MYOPATHY 25 0.0029
475 FINGER DEFORMITY 14 0.0029
476 HAEMATOCRIT DECREASED 57 0.0029
477 APLASTIC ANAEMIA 15 0.0029
478 PARTIAL SEIZURES 15 0.0029
479 RECTAL HAEMORRHAGE 123 0.0029
480 BLOOD PRESSURE SYSTOLIC DECREASED 13 0.0029
481 HYPOCALCAEMIA 54 0.0029
482 ABDOMINAL HERNIA 13 0.0028
483 THERAPEUTIC PRODUCT EFFECT DECREASED 127 0.0028
484 REBOUND EFFECT 32 0.0028
485 RENAL IMPAIRMENT 237 0.0028
486 IRON DEFICIENCY ANAEMIA 26 0.0028
487 PANCREATITIS 148 0.0028
488 DRUG TOXICITY 38 0.0028
489 HERPES VIRUS INFECTION 16 0.0028
490 HAEMOGLOBIN DECREASED 285 0.0028
491 CARDIOMYOPATHY 41 0.0028
492 DERMATITIS BULLOUS 20 0.0028
493 PNEUMONITIS 75 0.0028
494 BLOOD DISORDER 22 0.0027
495 HYPOVOLAEMIA 16 0.0027
496 ENDOCARDITIS 14 0.0027
497 SKIN PLAQUE 23 0.0027
498 ACUTE KIDNEY INJURY 417 0.0027
499 HYPOTHYROIDISM 87 0.0027
500 RHABDOMYOLYSIS 113 0.0027
501 PRODUCT PRESCRIBING ISSUE 59 0.0027
502 CEREBRAL INFARCTION 66 0.0027
503 HYPERTENSIVE CRISIS 30 0.0027
504 PREMATURE BABY 80 0.0027
505 HEPATITIS C 32 0.0026
506 SEPSIS 295 0.0026
507 TRICUSPID VALVE INCOMPETENCE 21 0.0026
508 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0026
509 HAEMATOCHEZIA 145 0.0026
510 VOMITING 1232 0.0026
511 LUNG DISORDER 127 0.0026
512 HAEMOLYSIS 20 0.0026
513 HYPOGAMMAGLOBULINAEMIA 17 0.0026
514 FISTULA 29 0.0026
515 BLOOD PRESSURE DIASTOLIC DECREASED 19 0.0026
516 HYPONATRAEMIA 144 0.0026
517 SUDDEN DEATH 27 0.0025
518 SKIN DISORDER 85 0.0025
519 WHITE BLOOD CELL COUNT INCREASED 97 0.0025
520 PEMPHIGOID 19 0.0025
521 ODYNOPHAGIA 15 0.0025
522 HEPATIC CIRRHOSIS 47 0.0025
523 SENSORY LOSS 20 0.0025
524 TOXICITY TO VARIOUS AGENTS 417 0.0025
525 HYPOACUSIS 106 0.0025
526 NEUROLOGICAL SYMPTOM 14 0.0024
527 HYPOXIA 86 0.0024
528 MENTAL STATUS CHANGES 67 0.0024
529 RENAL FAILURE ACUTE 102 0.0024
530 ADRENAL INSUFFICIENCY 29 0.0024
531 BRONCHOSPASM 34 0.0024
532 MYOCARDIAL ISCHAEMIA 27 0.0024
533 COUGH 665 0.0024
534 INFUSION RELATED REACTION 157 0.0024
535 NEUTROPENIA 322 0.0024
536 HYPERKALAEMIA 83 0.0024
537 INTENTIONAL PRODUCT USE ISSUE 207 0.0024
538 AUTISM SPECTRUM DISORDER 13 0.0024
539 GASTRIC DISORDER 80 0.0023
540 CARDIAC FAILURE CONGESTIVE 187 0.0023
541 ESCHERICHIA INFECTION 19 0.0023
542 RASH ERYTHEMATOUS 110 0.0023
543 CARDIAC ARREST 189 0.0023
544 CONDITION AGGRAVATED 692 0.0023
545 BLOOD POTASSIUM DECREASED 68 0.0023
546 CHOLANGITIS 14 0.0023
547 VISUAL ACUITY REDUCED 75 0.0023
548 DECREASED APPETITE 524 0.0023
549 NEPHROPATHY 21 0.0022
550 PRODUCT USE IN UNAPPROVED INDICATION 556 0.0022
551 ABDOMINAL PAIN 521 0.0022
552 OXYGEN SATURATION DECREASED 125 0.0022
553 STAPHYLOCOCCAL INFECTION 73 0.0022
554 LYMPHOCYTE COUNT DECREASED 39 0.0022
555 AGRANULOCYTOSIS 41 0.0022
556 NIGHT SWEATS 71 0.0022
557 ANKYLOSING SPONDYLITIS 29 0.0022
558 DISEASE RECURRENCE 104 0.0022
559 SEIZURE 252 0.0022
560 GOUT 39 0.0022
561 FUNGAL INFECTION 72 0.0022
562 NODULE 28 0.0021
563 APPENDICITIS 20 0.0021
564 DELIRIUM 74 0.0021
565 ABSCESS 34 0.0021
566 SKIN REACTION 30 0.0021
567 BLOOD PRESSURE FLUCTUATION 51 0.0021
568 CYTOPENIA 26 0.0021
569 FOETAL EXPOSURE DURING PREGNANCY 172 0.0021
570 HYPOGLYCAEMIA 101 0.0021
571 PERITONITIS BACTERIAL 21 0.0021
572 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
573 DEVICE RELATED INFECTION 32 0.0021
574 HYPERAESTHESIA 17 0.0021
575 SINUS BRADYCARDIA 20 0.0021
576 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0021
577 HAEMATEMESIS 52 0.0020
578 ENTERITIS 13 0.0020
579 PERITONITIS 42 0.0020
580 CHOLECYSTITIS 24 0.0020
581 IMMUNODEFICIENCY 30 0.0020
582 PULMONARY OEDEMA 90 0.0020
583 TENDONITIS 31 0.0020
584 NAUSEA 1580 0.0020
585 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 19 0.0020
586 RHINITIS 16 0.0020
587 HYPOTHERMIA 20 0.0020
588 BLOOD POTASSIUM INCREASED 32 0.0020
589 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 108 0.0020
590 DYSPNOEA EXERTIONAL 74 0.0020
591 ARRHYTHMIA 93 0.0020
592 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 102 0.0020
593 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 139 0.0020
594 ABDOMINAL PAIN UPPER 398 0.0019
595 TACHYCARDIA 171 0.0019
596 RED BLOOD CELL COUNT DECREASED 55 0.0019
597 HYPOPHAGIA 49 0.0019
598 THERAPY NON-RESPONDER 86 0.0019
599 OEDEMA PERIPHERAL 232 0.0019
600 RASH PRURITIC 103 0.0019
601 OFF LABEL USE 1661 0.0019
602 WEIGHT DECREASED 529 0.0019
603 COMA 90 0.0019
604 FEELING DRUNK 14 0.0019
605 DYSPEPSIA 185 0.0019
606 VENTRICULAR TACHYCARDIA 31 0.0019
607 BACTERIAL INFECTION 35 0.0019
608 GENERAL PHYSICAL HEALTH DETERIORATION 217 0.0019
609 MITRAL VALVE INCOMPETENCE 21 0.0019
610 BLOOD PRESSURE SYSTOLIC INCREASED 36 0.0018
611 SHOCK HAEMORRHAGIC 15 0.0018
612 PLATELET COUNT DECREASED 196 0.0018
613 HICCUPS 15 0.0018
614 DEPRESSED LEVEL OF CONSCIOUSNESS 72 0.0018
615 PHOTOSENSITIVITY REACTION 30 0.0018
616 ACUTE CORONARY SYNDROME 15 0.0018
617 HALLUCINATION, VISUAL 38 0.0018
618 ELECTROCARDIOGRAM ABNORMAL 14 0.0018
619 UPPER GASTROINTESTINAL HAEMORRHAGE 30 0.0018
620 INTESTINAL PERFORATION 20 0.0018
621 DIPLOPIA 46 0.0018
622 SECRETION DISCHARGE 22 0.0018
623 INTESTINAL OBSTRUCTION 66 0.0017
624 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
625 LUNG INFECTION 27 0.0017
626 TENDERNESS 18 0.0017
627 PERICARDITIS 29 0.0017
628 ARTHRALGIA 714 0.0017
629 FOLLICULITIS 18 0.0017
630 URINE OUTPUT DECREASED 15 0.0017
631 OEDEMA 93 0.0017
632 OSTEOMYELITIS 31 0.0017
633 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 14 0.0017
634 BLINDNESS 69 0.0017
635 PHARYNGITIS 21 0.0017
636 HYPERTENSION 356 0.0017
637 DYSPHONIA 98 0.0017
638 DYSARTHRIA 63 0.0017
639 HAEMATURIA 57 0.0017
640 NEUTROPHIL COUNT INCREASED 17 0.0017
641 DYSPNOEA 934 0.0016
642 OESOPHAGITIS 18 0.0016
643 PNEUMONIA 533 0.0016
644 PNEUMONIA ASPIRATION 41 0.0016
645 ABDOMINAL DISCOMFORT 274 0.0016
646 MENTAL DISORDER 71 0.0016
647 BODY TEMPERATURE INCREASED 33 0.0016
648 PALLOR 44 0.0016
649 LETHARGY 93 0.0016
650 CHOLELITHIASIS 53 0.0016
651 ILEUS 20 0.0016
652 DEEP VEIN THROMBOSIS 104 0.0016
653 SPINAL OSTEOARTHRITIS 14 0.0016
654 SQUAMOUS CELL CARCINOMA 15 0.0016
655 SKIN ULCER 41 0.0016
656 MUSCLE ATROPHY 20 0.0016
657 HAEMATOTOXICITY 15 0.0016
658 CHILLS 185 0.0016
659 SUBARACHNOID HAEMORRHAGE 16 0.0016
660 MUCOSAL INFLAMMATION 41 0.0016
661 BLOOD PRESSURE DECREASED 103 0.0015
662 INTENTIONAL OVERDOSE 99 0.0015
663 GINGIVAL BLEEDING 21 0.0015
664 RENAL FAILURE 203 0.0015
665 COVID-19 PNEUMONIA 18 0.0015
666 ASTHENIA 571 0.0015
667 SUICIDE ATTEMPT 92 0.0015
668 RASH 658 0.0015
669 EPILEPSY 46 0.0015
670 MASS 21 0.0015
671 RESPIRATORY TRACT INFECTION 39 0.0015
672 DISEASE PROGRESSION 177 0.0015
673 ARTERIOSCLEROSIS 14 0.0015
674 ERYTHEMA 304 0.0015
675 RESPIRATORY DISORDER 44 0.0015
676 EAR DISCOMFORT 15 0.0015
677 HYPERGLYCAEMIA 53 0.0015
678 SPINAL PAIN 17 0.0014
679 CELLULITIS 73 0.0014
680 NERVOUS SYSTEM DISORDER 45 0.0014
681 PULMONARY EMBOLISM 137 0.0014
682 VENTRICULAR FIBRILLATION 16 0.0014
683 INFLAMMATION 74 0.0014
684 DERMATITIS 30 0.0014
685 RASH GENERALISED 37 0.0014
686 THERAPY PARTIAL RESPONDER 22 0.0014
687 MANIA 23 0.0014
688 WHITE BLOOD CELL COUNT DECREASED 151 0.0014
689 HERPES ZOSTER 80 0.0014
690 RESPIRATORY DEPRESSION 17 0.0014
691 PHOTOPHOBIA 26 0.0014
692 CONFUSIONAL STATE 221 0.0014
693 CARDIO-RESPIRATORY ARREST 57 0.0014
694 HYPOTENSION 273 0.0014
695 ABDOMINAL DISTENSION 142 0.0014
696 BLOOD CREATINE PHOSPHOKINASE INCREASED 39 0.0014
697 FOOT DEFORMITY 15 0.0014
698 SEASONAL ALLERGY 19 0.0013
699 HYPERLIPIDAEMIA 16 0.0013
700 RASH PAPULAR 30 0.0013
701 OSTEOPOROSIS 55 0.0013
702 CONVULSION 76 0.0013
703 MALAISE 582 0.0013
704 MYDRIASIS 17 0.0013
705 MYALGIA 225 0.0013
706 DIARRHOEA 852 0.0013
707 HYPERSENSITIVITY 244 0.0013
708 DISORIENTATION 52 0.0013
709 DEHYDRATION 175 0.0013
710 FLUID OVERLOAD 19 0.0013
711 CARDIOMEGALY 16 0.0013
712 SMALL INTESTINAL OBSTRUCTION 16 0.0013
713 BEDRIDDEN 17 0.0013
714 MUSCULOSKELETAL CHEST PAIN 20 0.0013
715 COORDINATION ABNORMAL 18 0.0013
716 UNRESPONSIVE TO STIMULI 33 0.0013
717 WOUND INFECTION 14 0.0013
718 HYPOAESTHESIA 191 0.0013
719 POISONING 16 0.0013
720 HEADACHE 794 0.0013
721 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
722 PRODUCT USE ISSUE 237 0.0013
723 HALLUCINATION, AUDITORY 20 0.0013
724 PARALYSIS 18 0.0013
725 ULCER 20 0.0013
726 ANHEDONIA 33 0.0013
727 ACUTE MYOCARDIAL INFARCTION 37 0.0013
728 CARDIOGENIC SHOCK 18 0.0013
729 OSTEOPENIA 19 0.0013
730 LOSS OF CONSCIOUSNESS 160 0.0012
731 PRURITUS GENERALISED 27 0.0012
732 CHEST PAIN 231 0.0012
733 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
734 MATERNAL EXPOSURE DURING PREGNANCY 110 0.0012
735 CIRCULATORY COLLAPSE 21 0.0012
736 SYNCOPE 123 0.0012
737 EJECTION FRACTION DECREASED 19 0.0012
738 CYANOSIS 19 0.0012
739 VISUAL IMPAIRMENT 149 0.0012
740 ANAPHYLACTIC SHOCK 31 0.0012
741 VIRAL INFECTION 40 0.0012
742 MUSCULOSKELETAL STIFFNESS 105 0.0012
743 HYPOAESTHESIA ORAL 18 0.0012
744 ECONOMIC PROBLEM 18 0.0012
745 RENAL INJURY 35 0.0012
746 ATRIAL FIBRILLATION 114 0.0012
747 DRUG INEFFECTIVE 1522 0.0012
748 PALPITATIONS 135 0.0012
749 ABDOMINAL PAIN LOWER 29 0.0011
750 APHONIA 16 0.0011
751 ANAPHYLACTIC REACTION 63 0.0011
752 CONJUNCTIVITIS 21 0.0011
753 HAEMORRHOIDS 22 0.0011
754 JOINT SWELLING 136 0.0011
755 DIABETIC KETOACIDOSIS 27 0.0011
756 SENSORY DISTURBANCE 18 0.0011
757 DYSURIA 41 0.0011
758 URINARY INCONTINENCE 33 0.0011
759 HEART RATE IRREGULAR 25 0.0011
760 LYMPHOMA 17 0.0011
761 BRADYCARDIA 58 0.0011
762 VISION BLURRED 150 0.0011
763 PERIPHERAL COLDNESS 15 0.0011
764 MELAENA 24 0.0011
765 PRURITUS 419 0.0011
766 AGITATION 80 0.0011
767 ANGIOEDEMA 48 0.0011
768 INFECTION 157 0.0011
769 HEART RATE DECREASED 38 0.0011
770 UPPER RESPIRATORY TRACT INFECTION 50 0.0011
771 DIABETES MELLITUS INADEQUATE CONTROL 19 0.0011
772 BLISTER 60 0.0011
773 COMPLETED SUICIDE 89 0.0011
774 VERTIGO 65 0.0011
775 GASTROINTESTINAL HAEMORRHAGE 89 0.0011
776 TOOTH INFECTION 14 0.0011
777 THERAPEUTIC RESPONSE DECREASED 64 0.0011
778 RESPIRATORY ARREST 29 0.0011
779 ABORTION SPONTANEOUS 42 0.0010
780 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
781 INCORRECT DRUG ADMINISTRATION DURATION 29 0.0010
782 NEUTROPHIL COUNT DECREASED 42 0.0010
783 DELUSION 16 0.0010
784 RASH MACULAR 36 0.0010
785 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 30 0.0010
786 CONSTIPATION 223 0.0010
787 FAECES DISCOLOURED 22 0.0010
788 ANGINA PECTORIS 29 0.0010
789 DIABETES MELLITUS 77 0.0010
790 FEBRILE NEUTROPENIA 67 0.0010
791 ARTHRITIS 79 0.0010
792 MUSCULAR WEAKNESS 114 0.0010
793 GASTRIC ULCER 19 0.0010
794 SKIN EXFOLIATION 84 0.0010
795 PARANOIA 17 0.0010
796 DIZZINESS 482 0.0010
797 PARAESTHESIA 152 0.0010
798 WOUND 27 0.0010
799 PULMONARY HYPERTENSION 20 0.0010
800 INFLUENZA 107 0.0010
801 CATARACT 57 0.0010
802 GALLBLADDER DISORDER 17 0.0010
803 PERIPHERAL SWELLING 146 0.0009
804 OSTEONECROSIS 31 0.0009
805 HAEMORRHAGE INTRACRANIAL 14 0.0009
806 MUSCULOSKELETAL PAIN 49 0.0009
807 BRONCHITIS 69 0.0009
808 END STAGE RENAL DISEASE 17 0.0009
809 TREMOR 154 0.0009
810 ORAL HERPES 18 0.0009
811 OSTEOARTHRITIS 39 0.0009
812 DIALYSIS 13 0.0009
813 THERAPY INTERRUPTED 65 0.0009
814 RHEUMATOID ARTHRITIS 103 0.0009
815 CHEST DISCOMFORT 92 0.0009
816 URTICARIA 150 0.0009
817 EATING DISORDER 19 0.0009
818 FEAR 24 0.0009
819 FEEDING DISORDER 18 0.0009
820 CHRONIC KIDNEY DISEASE 67 0.0009
821 INTENTIONAL DOSE OMISSION 25 0.0009
822 MOVEMENT DISORDER 28 0.0009
823 CEREBRAL HAEMORRHAGE 31 0.0009
824 SOMNOLENCE 174 0.0009
825 FATIGUE 659 0.0008
826 BACK PAIN 195 0.0008
827 JOINT STIFFNESS 22 0.0008
828 HEART RATE INCREASED 83 0.0008
829 RENAL DISORDER 39 0.0008
830 RHINORRHOEA 54 0.0008
831 POST PROCEDURAL COMPLICATION 16 0.0008
832 EYE PAIN 47 0.0008
833 APHASIA 25 0.0008
834 PSORIASIS 108 0.0008
835 NEURALGIA 20 0.0008
836 IMPAIRED HEALING 27 0.0008
837 PAIN IN EXTREMITY 242 0.0008
838 EYE DISORDER 27 0.0008
839 DYSPHAGIA 77 0.0008
840 OROPHARYNGEAL PAIN 75 0.0008
841 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
842 NECK PAIN 45 0.0008
843 ORTHOSTATIC HYPOTENSION 14 0.0008
844 SPINAL FRACTURE 16 0.0008
845 HALLUCINATION 60 0.0008
846 BLOOD CHOLESTEROL INCREASED 37 0.0008
847 RESTLESSNESS 29 0.0008
848 INFLUENZA LIKE ILLNESS 65 0.0008
849 SYSTEMIC LUPUS ERYTHEMATOSUS 28 0.0008
850 DYSSTASIA 23 0.0008
851 DEPRESSION 179 0.0008
852 LOCALISED INFECTION 19 0.0008
853 ABNORMAL BEHAVIOUR 31 0.0008
854 PRESYNCOPE 19 0.0008
855 LABORATORY TEST ABNORMAL 23 0.0008
856 LIMB DISCOMFORT 24 0.0008
857 EPISTAXIS 58 0.0008
858 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
859 INSOMNIA 204 0.0008
860 SINUSITIS 78 0.0008
861 CORONARY ARTERY DISEASE 23 0.0008
862 PAIN 463 0.0008
863 GAIT DISTURBANCE 144 0.0008
864 CYTOKINE RELEASE SYNDROME 15 0.0007
865 ADVERSE DRUG REACTION 67 0.0007
866 URINARY TRACT INFECTION 127 0.0007
867 GYNAECOMASTIA 23 0.0007
868 SWELLING 69 0.0007
869 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
870 URINARY RETENTION 24 0.0007
871 HYPERHIDROSIS 92 0.0007
872 SWELLING FACE 46 0.0007
873 UPPER LIMB FRACTURE 14 0.0007
874 PREGNANCY 14 0.0007
875 IRRITABILITY 42 0.0007
876 DEATH 596 0.0007
877 WHEEZING 41 0.0007
878 PSORIATIC ARTHROPATHY 28 0.0007
879 ANXIETY 196 0.0007
880 FOOT FRACTURE 13 0.0007
881 AGGRESSION 34 0.0007
882 DYSGEUSIA 50 0.0007
883 ADVERSE EVENT 62 0.0007
884 GASTRIC CANCER 17 0.0007
885 EAR PAIN 13 0.0007
886 ARTHROPATHY 37 0.0007
887 PRODUCT AVAILABILITY ISSUE 15 0.0007
888 GAIT INABILITY 22 0.0007
889 SLEEP DISORDER 46 0.0007
890 POOR QUALITY SLEEP 14 0.0006
891 SPEECH DISORDER 34 0.0006
892 FEELING COLD 18 0.0006
893 FLUSHING 65 0.0006
894 MYOCARDIAL INFARCTION 111 0.0006
895 HAEMORRHAGE 66 0.0006
896 WEIGHT INCREASED 141 0.0006
897 BURNING SENSATION 44 0.0006
898 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 30 0.0006
899 BLOOD PRESSURE INCREASED 95 0.0006
900 GASTROOESOPHAGEAL REFLUX DISEASE 50 0.0006
901 MENTAL IMPAIRMENT 15 0.0006
902 DRUG EXPOSURE DURING PREGNANCY 21 0.0006
903 DIVERTICULITIS 17 0.0006
904 SUICIDAL IDEATION 56 0.0006
905 NEPHROLITHIASIS 28 0.0006
906 STOMATITIS 37 0.0006
907 HOSPITALISATION 93 0.0006
908 COGNITIVE DISORDER 28 0.0006
909 COVID-19 105 0.0006
910 INJECTION SITE PRURITUS 40 0.0006
911 CYSTITIS 19 0.0006
912 TYPE 2 DIABETES MELLITUS 20 0.0006
913 OVERDOSE 127 0.0006
914 DRY SKIN 77 0.0006
915 NASOPHARYNGITIS 106 0.0006
916 FEELING HOT 35 0.0006
917 MOBILITY DECREASED 41 0.0006
918 FLATULENCE 32 0.0006
919 DISTURBANCE IN ATTENTION 30 0.0006
920 DRY MOUTH 45 0.0006
921 ILLNESS 57 0.0006
922 POLLAKIURIA 23 0.0006
923 NASAL CONGESTION 32 0.0005
924 BONE DENSITY DECREASED 17 0.0005
925 DYSKINESIA 22 0.0005
926 ACNE 41 0.0005
927 ALOPECIA 106 0.0005
928 DEMENTIA 15 0.0005
929 THROAT IRRITATION 24 0.0005
930 ROAD TRAFFIC ACCIDENT 22 0.0005
931 ASTHMA 59 0.0005
932 BALANCE DISORDER 45 0.0005
933 NIGHTMARE 18 0.0005
934 ECZEMA 27 0.0005
935 LIMB INJURY 14 0.0005
936 MOOD ALTERED 14 0.0005
937 LIP SWELLING 17 0.0005
938 DRY EYE 25 0.0005
939 FLUID RETENTION 25 0.0005
940 MUSCLE SPASMS 90 0.0005
941 INJECTION SITE ERYTHEMA 59 0.0005
942 DISCOMFORT 29 0.0005
943 FALL 158 0.0005
944 OCULAR HYPERAEMIA 22 0.0005
945 LUNG NEOPLASM MALIGNANT 19 0.0005
946 ILL-DEFINED DISORDER 28 0.0005
947 DEPRESSED MOOD 24 0.0005
948 HEAD INJURY 14 0.0004
949 UNDERDOSE 32 0.0004
950 EYE SWELLING 16 0.0004
951 DRUG EFFECT DECREASED 23 0.0004
952 UNEVALUABLE EVENT 32 0.0004
953 CARDIAC DISORDER 39 0.0004
954 MEDICATION ERROR 23 0.0004
955 DRUG EFFECT INCOMPLETE 15 0.0004
956 CONTUSION 38 0.0004
957 BONE PAIN 23 0.0004
958 INJECTION SITE SWELLING 30 0.0004
959 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 70 0.0004
960 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
961 ACCIDENTAL OVERDOSE 14 0.0004
962 INJECTION SITE REACTION 26 0.0004
963 CEREBROVASCULAR ACCIDENT 64 0.0004
964 MIGRAINE 36 0.0004
965 BLOOD GLUCOSE DECREASED 18 0.0004
966 BLOOD GLUCOSE INCREASED 70 0.0004
967 THERAPY CESSATION 19 0.0004
968 INTENTIONAL PRODUCT MISUSE 32 0.0004
969 MEMORY IMPAIRMENT 50 0.0004
970 EMOTIONAL DISTRESS 44 0.0004
971 THROMBOSIS 29 0.0004
972 AMNESIA 23 0.0004
973 INCORRECT DOSE ADMINISTERED 80 0.0004
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
975 PRODUCT DOSE OMISSION ISSUE 93 0.0003
976 HOT FLUSH 23 0.0003
977 INJECTION SITE HAEMORRHAGE 24 0.0003
978 FEELING ABNORMAL 72 0.0003
979 INJECTION SITE PAIN 88 0.0003
980 SURGERY 16 0.0003
981 INJURY 19 0.0003
982 NEOPLASM MALIGNANT 18 0.0003
983 NERVOUSNESS 14 0.0003
984 MALIGNANT NEOPLASM PROGRESSION 25 0.0002
985 DEVICE MALFUNCTION 17 0.0002
986 INJECTION SITE BRUISING 19 0.0002
987 PRODUCT DOSE OMISSION 15 0.0002
988 DEVICE ISSUE 19 0.0002
989 DRUG DOSE OMISSION 32 0.0002
990 DRUG DEPENDENCE 30 0.0002
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
992 NO ADVERSE EVENT 22 0.0001